Global Veterinary Drug Competitive Landscape Professional Research Report 2024

Global Veterinary Drug Competitive Landscape Professional Research Report 2024

Research Summary

Veterinary drugs, also known as veterinary pharmaceuticals or veterinary medications, are substances used to prevent, diagnose, treat, or manage diseases, disorders, and health conditions in animals. These drugs are specifically formulated and regulated for use in veterinary medicine to ensure the safety, efficacy, and welfare of animals. Veterinary drugs encompass a wide range of products, including antibiotics, antiparasitics, vaccines, analgesics, anti-inflammatory drugs, anesthetics, sedatives, hormones, and nutritional supplements, among others. They may be administered orally, topically, parenterally (injection), or through other routes depending on the type of drug and the condition being treated. Veterinary drugs play a critical role in maintaining animal health, preventing the spread of diseases, supporting animal welfare, and ensuring the safety of animal-derived food products. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) oversee the approval, manufacturing, distribution, and use of veterinary drugs to ensure their safety and effectiveness for veterinary use.

According to DIResearch's in-depth investigation and research, the global Veterinary Drug market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Veterinary Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Veterinary Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Veterinary Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Veterinary Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Veterinary Drug Include:

Zoetis

Elanco

Boehringer Ingelheim

Merck

Virbac

Ceva

Vetoquinol

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

Veterinary Drug Product Segment Include:

Anti-Infectives

Anti-Inflammatory

Parasiticides

Analgesics

Sedatives

Others

Veterinary Drug Product Application Include:

Pets

Cattle

Poultry

Swine

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Veterinary Drug Industry PESTEL Analysis

Chapter 3: Global Veterinary Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global Veterinary Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Veterinary Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Veterinary Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Veterinary Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Veterinary Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Veterinary Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Veterinary Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Veterinary Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Veterinary Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources